HAEMONETICS CORP

For the period ended Sep 28, 2024. Filed Nov 7, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 28, 2024 · Filed Nov 7, 2024

HAE$118.21-1.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

ITEM 1. Financial Statements

CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

(Unaudited in thousands, except per share data)

	Three Months Ended		Six Months Ended
	September 28,2024	September 30,2023	September 28,2024	September 30,2023
Net revenues	$345,511	$318,183	$681,683	$629,515
Cost of goods sold	158,074	147,673	319,322	291,740
Gross profit	187,437	170,510	362,361	337,775
Operating expenses:
Research and development	16,530	12,665	30,979	25,313
Selling, general and administrative	106,946	115,320	215,194	208,805
Amortization of acquired intangible assets	12,264	7,222	24,735	14,695
Total operating expenses	135,740	135,207	270,908	248,813
Operating income	51,697	35,303	91,453	88,962
Interest and other expense, net	(6,993)	(2,471)	(36)	(4,540)
Income before provision for income taxes	44,704	32,832	91,417	84,422
Provision for income taxes	10,873	7,924	19,213	18,472
Net income	$33,831	$24,908	$72,204	$65,950
Net income per share - basic	$0.66	$0.49	$1.42	$1.30
Net income per share - diluted	$0.66	$0.48	$1.40	$1.28
Weighted average shares outstanding
Basic	50,898	50,727	50,920	50,634
Diluted	51,240	51,396	51,402	51,368
Comprehensive income	$41,934	$21,721	$73,272	$63,626

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.